Apadenoson is an adenosine A2A agonist. ATL-146e attenuates experimental posthemorrhagic vasospasm. ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. ATL-146e prevents concanavalin A-induced acute liver injury in mice. ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion.

250386-15-3

C23H30N6O6

486.52

ATL 146e;ATL-146e;ATL146e;BMS068645;BMS-068645;BMS 068645;Apadenoson

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years